Immucell (ICCC) Cash from Operations Growth (1y) (2011 - 2025)
Powered by 
Analysis
Immucell (ICCC) Cash from Operations Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 86.90% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 8.26% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 16.88% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 13.27% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 27.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15,915.83% |
| Sep 30, 2025 | -84.97% |
| Jun 30, 2025 | 175.28% |
| Mar 31, 2025 | 276.06% |
| Dec 31, 2024 | 99.58% |
| Sep 30, 2024 | -25.91% |
| Jun 30, 2024 | 185.38% |
| Mar 31, 2024 | 115.15% |
| Dec 31, 2023 | 44.29% |
| Sep 30, 2023 | 59.64% |
| Jun 30, 2023 | -282.46% |
| Mar 31, 2023 | -532.55% |
| Dec 31, 2022 | -320.76% |
| Sep 30, 2022 | -585.75% |
| Jun 30, 2022 | -48.90% |
| Mar 31, 2022 | 202.40% |
| Dec 31, 2021 | 276.26% |
| Sep 30, 2021 | 138.81% |
| Jun 30, 2021 | -24.59% |
| Mar 31, 2021 | -172.72% |